# Sofia 2 Lyme FIA Whole Blood Clinical Study

> **NCT03238274** · — · COMPLETED · sponsor: **Quidel Corporation** · enrollment: 597 (actual)

## Conditions studied

- Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)

## Interventions

- **DEVICE:** Sofia 2 Lyme FIA testing

## Key facts

- **NCT ID:** NCT03238274
- **Lead sponsor:** Quidel Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-06
- **Primary completion:** 2017-12-15
- **Final completion:** 2017-12-15
- **Target enrollment:** 597 (ACTUAL)
- **Last updated:** 2018-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03238274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03238274, "Sofia 2 Lyme FIA Whole Blood Clinical Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03238274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*